Johnson & Johnson JNJ and AstraZeneca AZN rank among the world’s largest pharmaceutical companies, each with a broad and ...

Johnson & Johnson (NYSE:JNJ) is one of the biggest pharmaceutical companies in the world. 2024 has been a very important year for the firm as it has agreed to pay a whopping $700 million to settle ...

Shares of European pharmaceutical companies sold off on Friday after President Donald Trump issued letters to 17 companies, ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Here are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.

Johnson & Johnson (NYSE:JNJ) has a sizable and broadly positioned operation, with strong representation in both the medical ...

The Trump administration has proposed a pilot initiative to address controversy over the 340B drug discount program.

The global pharmaceutical industry will generate about $1.2 trillion in sales in 2025, according to Statista. The oncology segment alone is expected to generate $217 billion in sales this year.

Johnson & Johnson (NYSE:JNJ) stock's investment case is highly correlated with its underlying dividend prospects. As a healthcare giant with iconic brands like Band-Aid and Listerine, along with a ...